Tag: Harm reduction

What do we owe people? Ethics and the rollback of harm reduction programs in Canada

Canada is facing a drug policy contradiction. Governments continue to describe toxic drug deaths as a “serious public health crisis”, yet some are dismantling parts of the public health response designed to prevent overdoses, reduce infections and connect people to treatment and social supports. Public debate often asks whether programs such as supervised consumptions services (SCS) and safer supply  should have been implemented in the first place. That question matters. But once these programs exist and you take them away, another ethics question arises: what do governments owe people who have come to depend on these programs for survival? Ending...

Read more

When evidence, economic arguments and the law aren’t enough: Responding to political attacks on harm reduction

Across Canada, harm reduction is under attack. Innovative and evidence-informed programs have been cut, reversed and shuttered. Politicians are retreating from progressive drug policies. Where Canadians were once global leaders in harm reduction, now governments at all levels are retreating from harm reduction principles and practices. The contrast with where Canada once was and current Canadian drug policy is striking. Harm reduction advocates and their allies are fighting back. They are producing evidence briefs about health benefits and preventable deaths, making arguments about costs and launching legal challenges. But these efforts have not been enough to prevent shutting down harm...

Read more

Harm reduction persists: Returning to collective care

For more than a decade, communities across Canada have been experiencing tremendous harms associated with the growing toxicity of the unregulated drug supply. Responses to this crisis remain fragmented, and too often they are shaped more by politics than by evidence or need. In recent years, the already limited landscape of harm reduction services has contracted further as governments across Canada have cut funding and reduced support. However, harm reduction did not begin as government-funded policies or programs. It began as collective care. Roots of harm reduction Harm reduction in Canada originated in approaches built by people who use drugs...

Read more

National numbers don’t tell the whole story: Nova Scotia’s overdose deaths are rising

In 2024, the number of opioid-related deaths in Canada dropped by 17% compared with the previous year. Some factors contributing to the decline include changes in the unregulated toxic drug supply, naloxone availability and a decrease in the size of the population at risk of overdose. However, it’s crucial to recognize that although this national figure is encouraging, too many lives are still being lost. The number of opioid-related deaths remains extremely high compared with the period before synthetic opioids became widespread in the drug supply. These synthetic opioids include fentanyl and nitazenes, which are often mixed with synthetic benzodiazepines....

Read more

Scaling back harm reduction will scale up blood-borne infections

Following nearly a decade of leadership in responding to the toxic drug crisis, harm reduction programs in some parts of Canada are now being scaled back. In some communities, programs like supervised consumption services and safer drug use equipment distribution are being defunded, restricted or forced to close. This is despite strong evidence that supervised consumption services prevent overdose deaths, increase safer substance use practices, increase access to healthcare including treatment and mental health services and reduce public drug use. Safer drug use distribution programs, often referred to as needle and syringe programs, prevent viral infections like hepatitis C and...

Read more

Understanding the realities of PnP with the Chemstory/Chemstories podcast

PnP (for “party ’n play,” also called chemsex) is defined as the intentional use of psychoactive substances, such as methamphetamine, GHB or ketamine, in a sexual context. Because of the strong stigma surrounding the practice, people still too often experience this in silence, shame and isolation. It’s precisely to address this issue that researcher and professor Olivier Ferlatte, director of Qollab, a research laboratory located at the University of Montreal’s School of Public Health (ESPUM), designed and conceived the Chemstory/Chemstories research-action project. The project aims to hand the mic to the people directly concerned, meaning gay, bisexual and queer men, both...

Read more